Dipeptidyl peptidase-4 (DPP-4) is a serine aminopeptidase, commonly referred to as CD26, an enzyme that is necessary for regulating glucose metabolism [26] and immune function [27], and is one of the validated targets for diabetes therapy due to its regulatory effect on incretin hormones [28]. Here, DPP4 is linked to diabetes mellitus.